Motility News

The American Gastroenterological Association released new clinical practice guidelines for the evaluation of chronic diarrhea.

Patients with obesity are at greater risk for chronic diarrhea, and the association grew stronger as BMI increased, according to the results of a nationally representative survey.

The FDA on Thursday approved Ibsrela, a 50 mg, twice-daily oral therapy for irritable bowel syndrome with constipation in adults.

There is no definitive cure for patients suffering from gastroparesis.

Women with fecal incontinence experience negligible differences in improvement between primary interventions including anorectal manometry-assisted biofeedback, loperamide, education, and oral placebo, according to the results of a randomized factorial trial.

Mayo Clinic tops U.S. News & World Report’s 2019-2020 Best Hospitals rankings for adult gastroenterology and gastrointestinal surgery.

SAN DIEGO — Sacral nerve stimulation and antegrade continence enemas, when compared with each other, both offer positive experiences for children with severe constipation and each may best suit a different cohort of children, a presenter at Digestive Disease Week 2019 said.

SAN DIEGO — In this exclusive video from Digestive Disease Week, William Chey, MD, professor of medicine, and director of the GI Physiology Laboratory at University of Michigan Health System, discusses two studies from his team that were presented at the meeting.

Many patients with constipation might not even recognize their condition, leaving researchers from King’s College London to call for new diagnostic criteria and new efforts to improve public education.

SAN DIEGO — Velusetrag, an oral, highly selective 5-hydroxytryptamine receptor 4 agonist, effectively reduced symptoms and gastric emptying in patients with diabetic or idiopathic gastroparesis, according to research presented at Digestive Disease Week.